IP Library Granted Patent US 11,795,487
Granted Patent B2
US 11,795,487 · App. 16/634,267 · Granted Oct 24, 2023

Fungal cell with improved protein production capacity

Inventors: Mingtao Huang (Gothenburg, SE); Anastasia Krivoruchko (Gothenburg, SE); Florian David (Gothenburg, SE); Jens Nielsen (Gothenburg, SE)
Assignee: Melt & Marble AB
C12P21/00C07K14/395
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,795,487
App. No.
16/634,267
Granted
Oct 24, 2023
Kind
B2
Abstract

The present invention related to the provision of genetically modified fungal cells, such as yeast cells with an improved ability for producing and secreting different recombinant proteins. The improved ability is obtained by disruption in intracellular transport between the Golgi and the endosome. In particular embodiments, the disruption is achieved by downregulation or deletion of the gene encoding a Tda3p homolog. The fungal cell and method of the invention would allow for large-scale production of recombinant proteins in fungal cells.

Claims (9)

1. A fungal cell, wherein

said fungal cell comprises a disrupted endogenous gene encoding Tda3p or an endogenous Tda3p gene that is deleted; is genetically modified for reduced expression of at least one protein selected from a group consisting of Vps5p, Vps17p, Vps29p, Pep8p, and Vps35p, or any combination thereof, and comprises a gene encoding a recombinant protein,

wherein the fungal cell is Saccharomyces cerevisiae, Pichia pastoris, Ashbya gossypii, Saccharomyces boulardii, Zygosaccharomyces bailii, Kluyveromyces lactis, Rhodosporidium toruloides or Yarrowia lipolytica.

2. The fungal cell according to claim 1 , wherein said fungal cell comprises a heterologous gene encoding said recombinant protein.

3. A method for producing a recombinant protein comprising:

culturing a fungal cell according to claim 1 in a culture medium and in culture conditions suitable for production of said recombinant protein by said fungal cell; and

collecting said recombinant protein from said culture medium and/or from said fungal cell.

4. The fungal cell of claim 1 , wherein said fungal cell is a Saccharomyces cerevisiae cell, which is genetically modified for reduced expression of at least one protein selected from a group consisting of Vps5p (SEQ ID NO: 3), Vps17p (SEQ ID NO: 4), Vps29p (SEQ ID NO: 6), Pep8p (SEQ ID NO: 5), and Vps35p (SEQ ID NO: 7), and variants thereof having at least 80% homology to any of SEQ ID NO: 3-7.

5. The fungal cell of claim 4 , wherein the Saccharomyces cerevisiae cell comprises a heterologous gene encoding said recombinant protein.

Assignments (2)
CHANGE OF NAME Recorded Nov 8, 2021
From: BIOPETROLIA AB
To: MELT&MARBLE AB
Reel/Frame 058815/0658 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 27, 2021
From: KRIVORUCHKO, ANASTASIA; DAVID, FLORIAN; NIELSEN, JENS; HUANG, MINGTAO
To: BIOPETROLIA AB
Reel/Frame 057933/0901 →
Priority Claims (1)
SE 1750968-8 · Jul 31, 2017 · national
Continuity (1)
Related Publication 20200299742A1 · Sep 24, 2020